Sight Sciences (SGHT) Share-based Compensation Growth (1y) (2021 - 2026)
Sight Sciences (SGHT) Share-based Compensation Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.38 Bn | 176.08 Bn | 6.27 Bn | 9.69% |
| 2 | Stryker | 129.56 Bn | 126.68 Bn | 3.81 Bn | 37.62% |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn | 6.74% |
| 4 | Boston Scientific | 68.59 Bn | 67.13 Bn | 3.61 Bn | 12.16% |
| 5 | Edwards Lifesciences | 47.58 Bn | 43.90 Bn | 1.29 Bn | 12.94% |
| 6 | Dexcom | 28.65 Bn | 27.53 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn | 59.09% |
| 8 | Smith & Nephew | 27.05 Bn | 26.48 Bn | - | - |
| 9 | Koninklijke Philips | 25.59 Bn | 22.46 Bn | 2.07 Bn | -30.44% |
| 10 | Sight Sciences | 274.03 Mn | 189.07 Mn | 16.98 Mn | -32.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.76% |
| Dec 31, 2025 | -77.60% |
| Sep 30, 2025 | -67.50% |
| Jun 30, 2025 | -11.03% |
| Mar 31, 2025 | 123.32% |
| Dec 31, 2024 | 534.07% |
| Sep 30, 2024 | 11.72% |
| Jun 30, 2024 | 15.37% |
| Mar 31, 2024 | -46.07% |
| Dec 31, 2023 | -181.05% |
| Sep 30, 2023 | 19.64% |
| Jun 30, 2023 | 5.95% |
| Mar 31, 2023 | 40.92% |
| Dec 31, 2022 | 55.26% |
| Sep 30, 2022 | 69.72% |
| Jun 30, 2022 | 292.44% |
| Mar 31, 2022 | 802.53% |
| Dec 31, 2021 | 911.17% |
| Sep 30, 2021 | 1,050.91% |
| Jun 30, 2021 | 1,284.62% |